Can subtle changes in gene expression be consistently detected with different microarray platforms?

PubWeight™: 1.36‹?› | Rank: Top 10%

🔗 View Article (PMC 2335120)

Published in BMC Genomics on March 10, 2008

Authors

Paola Pedotti1, Peter A C 't Hoen, Erno Vreugdenhil, Geert J Schenk, Rolf Ham Vossen, Yavuz Ariyurek, Mattias de Hollander, Rowan Kuiper, Gertjan J B van Ommen, Johan T den Dunnen, Judith M Boer, Renée X de Menezes

Author Affiliations

1: Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. paola.pedotti@gmail.com

Articles citing this

Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms. Nucleic Acids Res (2008) 10.10

Mapping complex disease traits with global gene expression. Nat Rev Genet (2009) 7.44

A cross-platform analysis of 14,177 expression quantitative trait loci derived from lymphoblastoid cell lines. Genome Res (2013) 1.72

Both noncoding and protein-coding RNAs contribute to gene expression evolution in the primate brain. Genome Biol Evol (2010) 1.45

Relative power and sample size analysis on gene expression profiling data. BMC Genomics (2009) 1.21

Left ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy. Genomics (2009) 0.98

A cross-laboratory comparison of expression profiling data from normal human postmortem brain. Neuroscience (2010) 0.95

Abnormal gene expression in cerebellum of Npc1-/- mice during postnatal development. Brain Res (2010) 0.90

Influence of sex on gene expression in human corneal epithelial cells. Mol Vis (2009) 0.88

Early gene expression changes in spinal cord from SOD1(G93A) Amyotrophic Lateral Sclerosis animal model. Front Cell Neurosci (2013) 0.85

Identifying biomarkers as diagnostic tools in kidney transplantation. Expert Rev Mol Diagn (2011) 0.83

Multiple platform assessment of the EGF dependent transcriptome by microarray and deep tag sequencing analysis. BMC Genomics (2011) 0.82

Prediction of breast cancer metastasis by gene expression profiles: a comparison of metagenes and single genes. Cancer Inform (2012) 0.80

Gene expression in the human brain: the current state of the study of specificity and spatiotemporal dynamics. Child Dev (2012) 0.80

Measuring the effect of inter-study variability on estimating prediction error. PLoS One (2014) 0.79

DCLK1 variants are associated across schizophrenia and attention deficit/hyperactivity disorder. PLoS One (2012) 0.79

Comparative analysis of acute and chronic corticosteroid pharmacogenomic effects in rat liver: transcriptional dynamics and regulatory structures. BMC Bioinformatics (2010) 0.79

Qingfei Xiaoyan Wan alleviates asthma through multi-target network regulation. BMC Complement Altern Med (2013) 0.79

Integrated Left Ventricular Global Transcriptome and Proteome Profiling in Human End-Stage Dilated Cardiomyopathy. PLoS One (2016) 0.77

Platform dependence of inference on gene-wise and gene-set involvement in human lung development. BMC Bioinformatics (2009) 0.77

Influence of aromatase absence on the gene expression and histology of the mouse meibomian gland. Invest Ophthalmol Vis Sci (2013) 0.76

Mapping Novel Pathways in Cardiovascular Disease Using eQTL Data: The Past, Present, and Future of Gene Expression Analysis. Front Genet (2013) 0.76

Transcriptome responses to heat- and cold-stress in ladybirds (Cryptolaemus montrouzieri Mulasnt) analyzed by deep-sequencing. Biol Res (2015) 0.76

Articles cited by this

Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52

Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19

KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res (1999) 40.62

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol (2006) 30.90

GMAP: a genomic mapping and alignment program for mRNA and EST sequences. Bioinformatics (2005) 21.04

Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics (2002) 20.59

Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet (2005) 17.75

"Stemness": transcriptional profiling of embryonic and adult stem cells. Science (2002) 15.55

A stem cell molecular signature. Science (2002) 14.47

Multiple-laboratory comparison of microarray platforms. Nat Methods (2005) 11.74

A global test for groups of genes: testing association with a clinical outcome. Bioinformatics (2004) 10.82

Analyzing gene expression data in terms of gene sets: methodological issues. Bioinformatics (2007) 9.87

Evaluation of DNA microarray results with quantitative gene expression platforms. Nat Biotechnol (2006) 8.87

Comment on " 'Stemness': transcriptional profiling of embryonic and adult stem cells" and "a stem cell molecular signature". Science (2003) 8.79

Excitatory actions of gaba during development: the nature of the nurture. Nat Rev Neurosci (2002) 8.74

Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Res (2003) 8.08

Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics (2002) 7.07

Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res (2002) 6.70

Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc Natl Acad Sci U S A (2006) 6.26

Independence and reproducibility across microarray platforms. Nat Methods (2005) 6.26

Performance comparison of one-color and two-color platforms within the MicroArray Quality Control (MAQC) project. Nat Biotechnol (2006) 5.92

Design issues for cDNA microarray experiments. Nat Rev Genet (2002) 5.69

Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat Biotechnol (2006) 5.14

Experimental comparison and cross-validation of the Affymetrix and Illumina gene expression analysis platforms. Nucleic Acids Res (2005) 4.41

GABAergic excitation promotes neuronal differentiation in adult hippocampal progenitor cells. Neuron (2005) 4.03

Cross-platform comparability of microarray technology: intra-platform consistency and appropriate data analysis procedures are essential. BMC Bioinformatics (2005) 3.93

Getting the noise out of gene arrays. Science (2004) 3.91

Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. Clin Cancer Res (2005) 3.79

A sequence-oriented comparison of gene expression measurements across different hybridization-based technologies. Nat Biotechnol (2006) 3.68

Enhancing scatterplots with smoothed densities. Bioinformatics (2004) 3.60

Using RNA sample titrations to assess microarray platform performance and normalization techniques. Nat Biotechnol (2006) 3.13

An array of problems. Nat Rev Drug Discov (2005) 2.55

GABA itself promotes the developmental switch of neuronal GABAergic responses from excitation to inhibition. Cell (2001) 2.52

Microarray reality checks in the context of a complex disease. Nat Biotechnol (2004) 2.51

Group testing for pathway analysis improves comparability of different microarray datasets. Bioinformatics (2006) 2.37

Three microarray platforms: an analysis of their concordance in profiling gene expression. BMC Genomics (2005) 2.29

Doublecortin-like kinase functions with doublecortin to mediate fiber tract decussation and neuronal migration. Neuron (2006) 2.27

Genetic interactions between doublecortin and doublecortin-like kinase in neuronal migration and axon outgrowth. Neuron (2006) 2.24

Dysregulation of gene expression in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse substantia nigra. J Neurosci (2004) 2.24

GABA sets the tempo for activity-dependent adult neurogenesis. Trends Neurosci (2006) 2.23

A comparison of oligonucleotide and cDNA-based microarray systems. Physiol Genomics (2004) 2.21

Comparing the use of Affymetrix to spotted oligonucleotide microarrays using two retinal pigment epithelium cell lines. Mol Vis (2003) 1.77

Doublecortin-like kinase controls neurogenesis by regulating mitotic spindles and M phase progression. Neuron (2006) 1.74

Current issues for DNA microarrays: platform comparison, double linear amplification, and universal RNA reference. J Biotechnol (2004) 1.66

Statistical analysis of an RNA titration series evaluates microarray precision and sensitivity on a whole-array basis. BMC Bioinformatics (2006) 1.39

Statistical methods and microarray data. Nat Biotechnol (2007) 1.35

Arrays of hope. Cell (2006) 1.20

Catalytic and regulatory domains of doublecortin kinase-1. Biochemistry (2003) 1.01

Functional differences between two DCLK splice variants. Brain Res Mol Brain Res (2004) 0.99

Doublecortin-like, a microtubule-associated protein expressed in radial glia, is crucial for neuronal precursor division and radial process stability. Eur J Neurosci (2007) 0.99

The doublecortin and doublecortin-like kinase 1 genes cooperate in murine hippocampal development. Cereb Cortex (2006) 0.94

The microtubule-associated protein doublecortin-like regulates the transport of the glucocorticoid receptor in neuronal progenitor cells. Mol Endocrinol (2007) 0.91

A potential role for calcium / calmodulin-dependent protein kinase-related peptide in neuronal apoptosis: in vivo and in vitro evidence. Eur J Neurosci (2007) 0.81

Articles by these authors

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med (2004) 11.61

Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms. Nucleic Acids Res (2008) 10.10

Transcriptome and genome sequencing uncovers functional variation in humans. Nature (2013) 8.89

Local dystrophin restoration with antisense oligonucleotide PRO051. N Engl J Med (2007) 7.29

A promoter-level mammalian expression atlas. Nature (2014) 6.25

LOVD v.2.0: the next generation in gene variant databases. Hum Mutat (2011) 5.53

Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles. Am J Hum Genet (2008) 5.53

Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker. Hum Mutat (2008) 4.22

Locus Reference Genomic sequences: an improved basis for describing human DNA variants. Genome Med (2010) 4.19

Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21

LOVD: easy creation of a locus-specific sequence variation database using an "LSDB-in-a-box" approach. Hum Mutat (2005) 2.86

Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet (2012) 2.82

Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations. Hum Mutat (2009) 2.67

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial. Lancet Oncol (2010) 2.66

Mutations in SWI/SNF chromatin remodeling complex gene ARID1B cause Coffin-Siris syndrome. Nat Genet (2012) 2.63

High-resolution melting analysis (HRMA): more than just sequence variant screening. Hum Mutat (2009) 2.59

Reproducibility of high-throughput mRNA and small RNA sequencing across laboratories. Nat Biotechnol (2013) 2.53

Quantile smoothing of array CGH data. Bioinformatics (2004) 2.51

The value of data. Nat Genet (2011) 2.40

Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet (2005) 2.40

Prorenin induces intracellular signaling in cardiomyocytes independently of angiotensin II. Hypertension (2006) 2.39

Peters Plus syndrome is caused by mutations in B3GALTL, a putative glycosyltransferase. Am J Hum Genet (2006) 2.31

Planning the human variome project: the Spain report. Hum Mutat (2009) 2.22

Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients. Hum Mol Genet (2003) 2.17

Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions. Nucleic Acids Res (2012) 2.15

Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signaling. Nat Genet (2013) 2.11

Three genome-wide association studies and a linkage analysis identify HERC2 as a human iris color gene. Am J Hum Genet (2008) 2.09

Deep sequencing to reveal new variants in pooled DNA samples. Hum Mutat (2009) 2.04

Tumor-expressed B7-H1 and B7-DC in relation to PD-1+ T-cell infiltration and survival of patients with cervical carcinoma. Clin Cancer Res (2009) 2.04

PASSion: a pattern growth algorithm-based pipeline for splice junction detection in paired-end RNA-Seq data. Bioinformatics (2012) 1.95

Two-color multiplex ligation-dependent probe amplification: detecting genomic rearrangements in hereditary multiple exostoses. Hum Mutat (2004) 1.94

Copy number variation in regions flanked (or unflanked) by duplicons among patients with developmental delay and/or congenital malformations; detection of reciprocal and partial Williams-Beuren duplications. Eur J Hum Genet (2006) 1.93

T-box transcription factor TBX3 reprogrammes mature cardiac myocytes into pacemaker-like cells. Cardiovasc Res (2012) 1.91

Recommendations of the 2006 Human Variome Project meeting. Nat Genet (2007) 1.90

Standardizing mutation nomenclature: why bother? Hum Mutat (2003) 1.80

Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy. Neuromuscul Disord (2002) 1.72

A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One (2012) 1.72

Describing structural changes by extending HGVS sequence variation nomenclature. Hum Mutat (2011) 1.62

Gateways to the FANTOM5 promoter level mammalian expression atlas. Genome Biol (2015) 1.58

Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome. Blood (2008) 1.56

High-resolution whole-genome sequencing reveals that specific chromatin domains from most human chromosomes associate with nucleoli. Mol Biol Cell (2010) 1.56

Comprehensive detection of genomic duplications and deletions in the DMD gene, by use of multiplex amplifiable probe hybridization. Am J Hum Genet (2002) 1.55

Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense. Am J Hum Genet (2003) 1.52

Single molecule sequencing of free DNA from maternal plasma for noninvasive trisomy 21 detection. Clin Chem (2012) 1.52

Standard mutation nomenclature in molecular diagnostics: practical and educational challenges. J Mol Diagn (2007) 1.50

Guidelines for antisense oligonucleotide design and insight into splice-modulating mechanisms. Mol Ther (2008) 1.48

Targeted exon skipping in transgenic hDMD mice: A model for direct preclinical screening of human-specific antisense oligonucleotides. Mol Ther (2004) 1.46

Fluorescent labelling of cRNA for microarray applications. Nucleic Acids Res (2003) 1.46

AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration. FASEB J (2006) 1.44

Genetic variation in T-box binding element functionally affects SCN5A/SCN10A enhancer. J Clin Invest (2012) 1.43

New methods for next generation sequencing based microRNA expression profiling. BMC Genomics (2010) 1.38

Exploring the frontiers of therapeutic exon skipping for Duchenne muscular dystrophy by double targeting within one or multiple exons. Mol Ther (2006) 1.38

Phage display screening without repetitious selection rounds. Anal Biochem (2011) 1.36

A common reference for cDNA microarray hybridizations. Nucleic Acids Res (2002) 1.35

Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargement. Nat Genet (2012) 1.34

Practical guidelines addressing ethical issues pertaining to the curation of human locus-specific variation databases (LSDBs). Hum Mutat (2010) 1.33

High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance. Blood (2012) 1.32

CORE_TF: a user-friendly interface to identify evolutionary conserved transcription factor binding sites in sets of co-regulated genes. BMC Bioinformatics (2008) 1.31

How to catch all those mutations--the report of the third Human Variome Project Meeting, UNESCO Paris, May 2010. Hum Mutat (2010) 1.31

Large scale single nucleotide polymorphism discovery in unsequenced genomes using second generation high throughput sequencing technology: applied to turkey. BMC Genomics (2009) 1.31

Curating gene variant databases (LSDBs): toward a universal standard. Hum Mutat (2011) 1.30

Deletion and duplication screening in the DMD gene using MLPA. Eur J Hum Genet (2005) 1.30

Application of massive parallel sequencing to whole genome SNP discovery in the porcine genome. BMC Genomics (2009) 1.29

Leiden Open Variation Database of the MUTYH gene. Hum Mutat (2010) 1.28

Evaluation of Affymetrix Gene Chip sensitivity in rat hippocampal tissue using SAGE analysis. Serial Analysis of Gene Expression. Eur J Neurosci (2002) 1.27

Coffin-Siris syndrome and the BAF complex: genotype-phenotype study in 63 patients. Hum Mutat (2013) 1.27

Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options. Blood (2009) 1.26

Cross-species comparison of human and mouse intestinal polyps reveals conserved mechanisms in adenomatous polyposis coli (APC)-driven tumorigenesis. Am J Pathol (2008) 1.26

Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes. PLoS One (2011) 1.26

Genome-wide assessment of differential roles for p300 and CBP in transcription regulation. Nucleic Acids Res (2010) 1.25

Integrated analysis of DNA copy number and gene expression microarray data using gene sets. BMC Bioinformatics (2009) 1.25

The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia. Blood (2005) 1.25

Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2. Am J Hum Genet (2011) 1.24

Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation. Nucleic Acids Res (2012) 1.23

Acidobacterial community responses to agricultural management of soybean in Amazon forest soils. FEMS Microbiol Ecol (2012) 1.19

The complete chloroplast genome of 17 individuals of pest species Jacobaea vulgaris: SNPs, microsatellites and barcoding markers for population and phylogenetic studies. DNA Res (2011) 1.19

Rapid genotyping of blood group antigens by multiplex polymerase chain reaction and DNA microarray hybridization. Transfusion (2005) 1.18

Increased sensitivity of next generation sequencing-based expression profiling after globin reduction in human blood RNA. BMC Genomics (2012) 1.18

Gene expression profiling of the forming atrioventricular node using a novel tbx3-based node-specific transgenic reporter. Circ Res (2009) 1.18

Integrated analysis of microRNA and mRNA expression: adding biological significance to microRNA target predictions. Nucleic Acids Res (2013) 1.18

A comparison of rpoB and 16S rRNA as markers in pyrosequencing studies of bacterial diversity. PLoS One (2012) 1.17

The effects of low levels of dystrophin on mouse muscle function and pathology. PLoS One (2012) 1.16